Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Jolanda M de Vries

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Frontiers in Immunology|November 5, 2019
Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune FunctionFarhan Basit, I Jolanda M de Vries
Biomedicines|May 25, 2017
Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell MaturationSimone P Sittig, I Jolanda M de Vries, Gerty Schreibelt
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 22, 2024
Targeted nanomedicine for reprogramming the tumor innate immune system: From bench to bedsideKunal Pednekar, Julia Minnee, I Jolanda M de Vries, et al.
Frontiers in Immunology|November 21, 2018
Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune ResponseFarhan Basit, Till Mathan, David Sancho, et al.
Oncoimmunology|June 22, 2012
STATing the importance of immune modulation by platinum chemotherapeuticsStanleyson V Hato, I Jolanda M de Vries, W Joost Lesterhuis
Immunology Letters|December 3, 2014
Scientific contributions toward successful cancer immunotherapy in The NetherlandsCornelis J M Melief, Rik J Scheper, I Jolanda M de Vries
The Journal of Investigative Dermatology|December 31, 2010
IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1Jurjen Tel, Ruurd Torensma, Carl G Figdor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2014
Molecular pathways: the immunogenic effects of platinum-based chemotherapeuticsStanleyson V Hato, Andrea Khong, I Jolanda M de Vries, et al.
Oncoimmunology|June 27, 2013
Naturally circulating dendritic cells to vaccinate cancer patientsKalijn F Bol, Jurjen Tel, I Jolanda M de Vries, et al.
Nature Reviews. Immunology|September 15, 2007
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingPaul J Tacken, I Jolanda M de Vries, Ruurd Torensma, et al.
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Frontiers in Immunology|November 5, 2019
Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune FunctionFarhan Basit, I Jolanda M de Vries
Biomedicines|May 25, 2017
Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell MaturationSimone P Sittig, I Jolanda M de Vries, Gerty Schreibelt
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 22, 2024
Targeted nanomedicine for reprogramming the tumor innate immune system: From bench to bedsideKunal Pednekar, Julia Minnee, I Jolanda M de Vries, et al.
Frontiers in Immunology|November 21, 2018
Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune ResponseFarhan Basit, Till Mathan, David Sancho, et al.
Oncoimmunology|June 22, 2012
STATing the importance of immune modulation by platinum chemotherapeuticsStanleyson V Hato, I Jolanda M de Vries, W Joost Lesterhuis
Immunology Letters|December 3, 2014
Scientific contributions toward successful cancer immunotherapy in The NetherlandsCornelis J M Melief, Rik J Scheper, I Jolanda M de Vries
The Journal of Investigative Dermatology|December 31, 2010
IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1Jurjen Tel, Ruurd Torensma, Carl G Figdor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2014
Molecular pathways: the immunogenic effects of platinum-based chemotherapeuticsStanleyson V Hato, Andrea Khong, I Jolanda M de Vries, et al.
Oncoimmunology|June 27, 2013
Naturally circulating dendritic cells to vaccinate cancer patientsKalijn F Bol, Jurjen Tel, I Jolanda M de Vries, et al.
Nature Reviews. Immunology|September 15, 2007
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingPaul J Tacken, I Jolanda M de Vries, Ruurd Torensma, et al.
Pageof 22